Spindle cell neoplasms with novel LTK fusion - Expanding the spectrum of kinase fusion-positive soft tissue tumors

被引:2
|
作者
Yeung, Maximus C. F. [1 ]
Dermawan, Josephine K. [2 ]
Liu, Anthony P. Y. [3 ,4 ]
Lam, Albert Y. L. [5 ]
Antonescu, Cristina R. [6 ]
Shek, Tony W. H. [1 ]
机构
[1] Univ Hong Kong, Sch Clin Med, Dept Pathol, Hong Kong, Peoples R China
[2] Robert J Tomsich Pathol & Lab Med Inst, Cleveland Clin, Cleveland, OH USA
[3] Univ Hong Kong, Sch Clin Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[4] Hong Kong Childrens Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China
[5] Univ Hong Kong, Sch Clin Med, Dept Orthoped & Traumatol, Div Gen Orthopaed & Oncol, Hong Kong, Peoples R China
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
来源
GENES CHROMOSOMES & CANCER | 2024年 / 63卷 / 03期
关键词
kinase fusion; LTK; MYH10; MYH9; soft tissue tumor; MAY-HEGGLIN; GENE FUSIONS; FECHTNER; MUTATIONS; EPSTEIN; MYH9;
D O I
10.1002/gcc.23227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AimsKinase fusion-positive soft tissue tumors represent an emerging, molecularly defined group of mesenchymal tumors with a wide morphologic spectrum and diverse activating kinases. Here, we present two cases of soft tissue tumors with novel LTK fusions. Methods and ResultsBoth cases presented as acral skin nodules (big toe and middle finger) in pediatric patients (17-year-old girl and 2-year-old boy). The tumors measured 2 and 3 cm in greatest dimension. Histologically, both cases exhibited bland-looking spindle cells infiltrating adipose tissue and accompanied by collagenous stroma. One case additionally displayed perivascular hyalinization and band-like stromal collagen. Both cases exhibited focal S100 staining, and one case had patchy coexpression of CD34. Targeted RNA-seq revealed the presence of novel in-frame MYH9::LTK and MYH10::LTK fusions, resulting in upregulation of LTK expression. Of interest, DNA methylation-based unsupervised clustering analysis in one case showed that the tumor clustered with dermatofibrosarcoma protuberans (DFSP). One tumor was excised with amputation with no local recurrence or distant metastasis at 18-month follow-up. The other case was initially marginally excised with local recurrence after one year, followed by wide local excision, with no evidence of disease at 10 years of follow-up. ConclusionsThis is the first reported case series of soft tissue tumors harboring LTK fusion, expanding the molecular landscape of soft tissue tumors driven by activating kinase fusions. Furthermore, studies involving a larger number of cases and integrated genomic analyses will be warranted to fully elucidate the pathogenesis and classification of these tumors.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Spindle Cell Lesions with Oncogenic EGFR Kinase Domain Aberrations: Expanding the Spectrum of Protein Kinase- Related Mesenchymal Tumors
    Vallese, Silvia
    Barresi, Sabina
    Hiemcke-Jiwa, Laura
    Patrizi, Sara
    Kester, Lennart
    Giovannoni, Isabella
    Cardoni, Antonello
    Pedace, Lucia
    Nardini, Claudia
    Tancredi, Chantal
    Desideri, Martina
    von Deimling, Andreas
    Mura, Rosa M.
    Piga, Michela
    Errico, Maria E.
    Stracuzzi, Alessandra
    Alaggio, Rita
    Miele, Evelina
    Flucke, Uta
    MODERN PATHOLOGY, 2024, 37 (09)
  • [32] Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial
    Yilmaz, Feride
    Yasar, Serkan
    Mandel, Nil Molinas
    Kacan, Turgut
    Ozdemir, Melek
    Dogu, Gamze Gokoz
    Sengul, Nilay
    Meydan, Nezih
    Basal, Fatma Bugdayci
    Tolunay, Pinar Kubilay
    Hamamci, Melda Berber
    Dincer, Oguz Salih
    Bahceci, Aykut
    Ozer, Leyla
    Ajredini, Mirac
    Kirca, Onder
    Yersal, Ozlem
    Can, Orcun
    Gunaldi, Meral
    Demir, Gokhan
    Yalcin, Suayib
    TARGETED ONCOLOGY, 2024, 19 (06) : 957 - 964
  • [33] Efficacy and safety of larotrectinib in neurotrophic tyrosine receptor kinase fusion-positive solid tumors: A multicenter retrospective cohort study in Korea
    Lee, S.
    Yoon, S.
    Choi, W.
    Jung, H. A.
    Bae, S. B.
    Kim, C. G.
    Kim, H. R.
    Lee, K-w.
    Kang, E. J.
    Shin, K.
    Lim, D-j.
    Kim, . s.
    Park, S.
    Lee, K-e.
    Lee, Y.
    Kim, H. S.
    Kim, T. J.
    Kim, M. J.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2024, 35
  • [34] Novel EWSR1-UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas
    El Zein, Sophie
    Djeroudi, Lounes
    Reynaud, Stephanie
    Guillemot, Delphine
    Masliah-Planchon, Julien
    Frouin, Eleonore
    Nicolas, Nayla
    Le Loarer, Francois
    Daniel, Catherine
    Delattre, Olivier
    Pierron, Gaelle
    Watson, Sarah
    GENES CHROMOSOMES & CANCER, 2022, 61 (04): : 200 - 205
  • [35] Soft tissue tumor with BRAF and NRAS mutations sharing features with NTRK-rearranged spindle cell neoplasm: A case report expanding the spectrum of spindle cell tumor with kinase gene alterations
    Kakuda, Yuko
    Kato, Ikuma
    Kawata, Takuya
    Goto, Keisuke
    Ito, Kan
    Satake, Ryo
    Toki, Shunichi
    Murata, Hideki
    Wasa, Junji
    Katagiri, Hirohisa
    Takahashi, Mitsuru
    Nagashima, Takeshi
    Mori, Taro
    Oda, Yoshinao
    Sugino, Takashi
    Yamaguchi, Ken
    PATHOLOGY INTERNATIONAL, 2025, 75 (01) : 40 - 45
  • [36] Nodular Fasciitis and Soft Tissue Aneurysmal Bone Cyst: Expanding the Spectrum of USP6 Fusion Partners
    Chung, Catherine T.
    Shago, Mary
    Demicco, Elizabeth
    Kandel, Rita
    Charames, George S.
    Somers, Gino R.
    Swanson, David
    Dickson, Brendan C.
    LABORATORY INVESTIGATION, 2018, 98 : 20 - 20
  • [37] Nodular Fasciitis and Soft Tissue Aneurysmal Bone Cyst: Expanding the Spectrum of USP6 Fusion Partners
    Chung, Catherine T.
    Shago, Mary
    Demicco, Elizabeth
    Kandel, Rita
    Charames, George S.
    Somers, Gino R.
    Swanson, David
    Dickson, Brendan C.
    MODERN PATHOLOGY, 2018, 31 : 20 - 20
  • [38] A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors
    Drilon, Alexander
    Nagasubramanian, Ramamoorthy
    Blake, James F.
    Ku, Nora
    Tuch, Brian B.
    Ebata, Kevin
    Smith, Steve
    Lauriault, Veronique
    Kolakowski, Gabrielle R.
    Brandhuber, Barbara J.
    Larsen, Paul D.
    Bouhana, Karyn S.
    Winski, Shannon L.
    Hamor, Robyn
    Wu, Wen-I
    Parker, Andrew
    Morales, Tony H.
    Sullivan, Francis X.
    DeWolf, Walter E.
    Wollenberg, Lance A.
    Gordon, Paul R.
    Douglas-Lindsay, Dorothea N.
    Scaltriti, Maurizio
    Benayed, Ryma
    Raj, Sandeep
    Hanusch, Bethany
    Schram, Alison M.
    Jonsson, Philip
    Berger, Michael F.
    Hechtman, Jaclyn F.
    Taylor, Barry S.
    Andrews, Steve
    Rothenberg, Michael
    Hyman, David M.
    CANCER DISCOVERY, 2017, 7 (09) : 963 - 972
  • [39] Calcifying Spindle Cell Soft Tissue Tumor With SOX10::PLAG1 Fusion: A Case Report of a Morphologically Distinctive and Potentially Novel Soft Tissue Tumor
    Kosemehmetoglu, Kemal
    Mosaieby, Elaheh
    Steiner, Petr
    Vanecek, Tomas
    Baranovska-Andrigo, Vira
    Michal, Michael
    GENES CHROMOSOMES & CANCER, 2024, 63 (06):
  • [40] Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors
    Liu, Dazhi
    Offin, Michael
    Harnicar, Stephen
    Li, Bob T.
    Drilon, Alexander
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1247 - 1252